Telix Pharmaceuticals Ltd
TLX101-Px
brain cancer
Date
TBD
FDA decision · Date TBD estimated
What's at stake
An FDA complete response letter on TLX101-Px for brain cancer is in focus around Date TBD.
Primary source
· SEC 6-K
verified 13h ago
“There have been several significant challenges, specifically the Complete Response Letters received for TLX250-Px (Zircaix) and TLX101-Px (Pixclara).”